[1]
N. Kirsten, “Development and Validation of a Disease-specific Outcomes Tool for the Assessment of Patient Benefits of Treatment for Hidradenitis Suppurativa: the PBI-HS”, Acta Derm Venereol, vol. 105, p. adv41298, Mar. 2025.